Pharmaceutical compositions comprising silica microspheres
US10278917B2 · kind B2 · utility
6Cited by
18References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2016 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Oct 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Topical vaginal compositions are disclosed herein which include silica microspheres and an active ingredient in the amount of 0.001 to 15.0% w/w selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The topical compositions provide sustained release of the active ingredient so as to reduce skin irritation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.